Adenovirus infections following allogeneic stem cell transplantation: Incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery

Blood

Volumn 100, Issue 5, 2002, Pages 1619-1627

  Chakrabarti, Suparno ^a,b,c,d   Mautner, Vivien ^a,b,c   Osman, Husam ^a,b,c   Collingham, Kathryn E ^a,b,c   Fegan, Chris D ^a,b,c   Klapper, Paul E ^a,b,c   Moss, Paul A H ^a,b,c   Milligan, Donald W ^a,b,c  

^a BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^d BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; IMMUNOSUPPRESSIVE AGENT;

ADENOVIRUS; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; DRUG CONTRAINDICATION; DRUG WITHDRAWAL; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION RISK; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK MANAGEMENT; STEM CELL TRANSPLANTATION; VIRUS INFECTION; VIRUS ISOLATION;

EID: 0036720393     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-02-0377     Document Type: Article

References (29)

1. Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation
2. Rapid reconstitution of Epstein-Barr virus-specific T lymphocytes following allogeneic stem cell transplantation
3. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients
4. Adenovirus infections in patients undergoing bone marrow transplantation
5. Increased incidence of adenovirus disease in bone marrow transplant recipients
6. Evolving pathogens in allogeneic bone marrow transplantation: Increased fatal adenoviral infections
7. High incidence of adeno-and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine
8. Adenovirus infections in adult recipients of blood and marrow transplants
9. Adenovirus infections in hematopoietic stem cell transplant recipients
10. Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation
11. Adenovirus infection after pediatric bone marrow transplantation
12. Fulminant adenovirus hepatitis following unrelated bone marrow transplantation: Failure of intravenous ribavirin therapy
13. Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation
14. Adenovirus infections following haematopoietic cell transplantation: Is there a role for adoptive immunotherapy?
15. CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells
16. In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation
17. New method for the extraction of viral RNA and DNA from cerebrospinal fluid for use in the polymerase chain reaction assay
18. Adenovirus polymerase chain reaction assay for rapid diagnosis of conjunctivitis
19. Neutralisation of adenovirus infectivity by ascitic fluid from ovarian cancer patients
20. Pharmacokinetics of Campath-1H in BMT patients
21. Detection of adenovirus DNA in peripheral blood mononuclear cells by polymerase chain reaction assay
22. Prediction of severe disseminated adenovirus infection by serum PCR
23. Persistent enteral infections with adenovirus types 1 and 2 in infants: No evidence of reinfection
24. Adenoviral infection after allogeneic stem cell transplantation (SCT): Report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study
25. Characterisation of human T cell responses to adenovirus
26. + T-cell responses are not inhibited by E3-19K in the presence of gamma interferon
27. Adenovirus-pulsed dendritic cells stimulate human virus-specific T-cell responses in vitro
28. Ex vivo generation of cytotoxic T lymphocytes specific for one or two distinct viruses for the prophylaxis of patients receiving an allogeneic bone marrow transplant
29. Extensive cross-reactivity of adenovirus-specific cytotoxic T cells